In an Interim Management Statement UDG said: Group revenues and adjusted operating profits for the nine months to 30 June 2014 are ahead of the same period last year. Profit growth in the nine months to June has been driven by the strong performance of the Ashfield Commercial and Medical Services division.
Performance for the quarter to 30 June 2014 has been good. Group revenues and profits for the three months are ahead of the same period last year, with Ashfield becoming the largest profit contributing division for the first time.
Ashfield Commercial and Medical Services
Ashfield has leading market positions in the provision of contract sales outsourcing, healthcare communications and medical services to pharmaceutical manufacturers in major markets including North America, the UK and continental Europe.
Trading during the three months to June has been strong with revenues and profits well ahead of the same period last year. Profit growth was particularly strong within the healthcare communications businesses due to a combination of organic growth and acquisitions. The North American business again performed well and the greenfield Japanese business moved into profitability in the quarter.
In March, we acquired the KnowledgePoint360 business strengthening our existing offering in healthcare communications. Its integration is going to plan and the business has performed well since acquisition.
In July, we acquired Galliard and Nyxeon which adds scientific public relations to the range of services we offer in healthcare communications.
For the full RNS click UDG